Post-inpatient Attrition from Care “As Usual” in Veterans with Multiple Psychiatric Admissions by Bowersox, Nicholas W. et al.
Marquette University
e-Publications@Marquette
Psychology Faculty Research and Publications Psychology, Department of
12-1-2013
Post-inpatient Attrition from Care “As Usual” in
Veterans with Multiple Psychiatric Admissions
Nicholas W. Bowersox
Marquette University
Stephen M. Saunders
Marquette University, stephen.saunders@marquette.edu
Bertrand Berger
Clement J. Zablocki VA Hospital
Accepted version. Community Mental Health Journal, Vol. 49, No. 6 (December 2013): 694-703.
DOI. © 2017 Springer Nature Switzerland AG. Part of Springer Nature. Used with permission.
Sharable Link Provided by the Springer Nature SharedIt content-sharing initiative.
 Marquette University 
e-Publications@Marquette 
 
Psychology Faculty Research and Publications/College of Arts and Sciences 
 
This paper is NOT THE PUBLISHED VERSION; but the author’s final, peer-reviewed manuscript. The 
published version may be accessed by following the link in the citation below. 
 
Community Mental Health Journal, Vol. 49, No. 6 (December, 2013): 694-703. DOI. This article is © 
Springer and permission has been granted for this version to appear in e-Publications@Marquette. 
Springer does not grant permission for this article to be further copied/distributed or hosted elsewhere 
without the express permission from Springer.  
 
Post-inpatient Attrition from Care “As Usual” in Veterans 
with Multiple Psychiatric Admissions 
 
Nicholas W. Bowersox 
Serious Mental Illness Treatment Research and Evaluation Center, Ann Arbor, MI  
Stephen M. Saunders 
Marquette University, Milwaukee, Wi 
Bertrand Berger 
Clement J. Zablocki VA, Hospital Milwaukee, WI 
 
Abstract 
Disengagement from outpatient care following psychiatric hospitalization is common in high-utilizing 
psychiatric patients and contributes to intensive care utilization. To investigate variables related to 
treatment attrition, a range of demographic, diagnostic, cognitive, social, and behavioral variables were 
collected from 233 veterans receiving inpatient psychiatric services who were then monitored over the 
following 2 years. During the follow-up period, 88.0 % (n = 202) of patients disengaged from post-
inpatient care. Attrition was associated with male gender, younger age, increased expectations of 
stigma, less short-term participation in group therapy, and poorer medication adherence. Of those who 
left care, earlier attrition was predicted by fewer prior-year inpatient psychiatric days, fewer lifetime 
psychiatric hospitalizations, increased perceived treatment support from family, and less short-term 
attendance at psychiatrist appointments. Survival analyses were used to analyze the rate of attrition of 
the entire sample as well as the sample split by short-term group therapy attendance. Implications are 
discussed. 
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Introduction 
A subset of psychiatric patients accounts for a sizable proportion of emergency psychiatric 
service use. These patients are characterized by multiple inpatient psychiatric admissions, 
limited engagement in outpatient psychiatric care (Walker et al. 1996; Kent and Yellowlees 
1994), and increased disability (Webb et al. 2007). Such patients constitute approximately 10–
20 % of psychiatric patients (Bobo et al. 2004; Roick et al. 2004; Vogel and Hugelet 1997) 
while accounting for a disproportionately large percentage of mental health costs. 
There are somewhat inconsistent findings related to the level of post-inpatient care attrition of 
this group, in part due to inconsistencies in the definition and measurement of attrition (O’Brien 
et al. 2009). One review found that rates of attrition ranged from 18–67 % across various 
studies, with a median rate of 58 % (Kreyenbuhl et al. 2009). Additionally, a review of long-
term treatment studies found that approximately 30 % of psychiatric patients left mental health 
care over periods ranging from 1–9 years (O’Brien et al. 2009). Additional work appears 
necessary to clarify of how common care attrition is for psychiatric patients, but there is 
consensus that the rate is unacceptably high. 
High rates of inpatient psychiatric service use of this population may be, in part, due to limited 
outpatient mental health treatment participation following discharge from inpatient psychiatric 
care. Outpatient treatments designed to address elevated psychiatric symptoms have been 
shown to be effective if patients are actively engaged (e.g., Lehman and Steinwachs 2003), 
and a lack of participation in outpatient mental health treatment has been linked to psychiatric 
readmission (Nelson et al. 2000; Prince 2005). This suggests the importance of keeping 
patients involved in treatment following discharge in order to reduce the “revolving-door” 
phenomena of repeated discharges and re-admissions to inpatient psychiatric care. Further 
supporting this idea, patient participation in mandatory outpatient psychiatric care has been 
demonstrated to result in reduced psychiatric admissions (Hunt et al. 2007; Rohland et al. 
2000). 
Although precise figures are difficult to establish, treatment attrition is a substantial concern 
with high utilizing psychiatric patients. Several variables have been implicated to play a role in 
treatment engagement following discharge from inpatient psychiatric care, including patient 
characteristics, patients’ attitude towards treatment, social support, and patients’ prior 
treatment experiences. 
Demographic and Clinical Characteristics 
Research suggests that the psychiatric patients most likely to leave treatment prematurely tend 
to be younger, male, and members of racial/ethnic minority groups (Fischer et al. 2001; Kruse 
et al. 2002; McCarthy et al. 2007). Increased attrition has also been linked to the presence of 
comorbid substance use disorders and to more severe levels of psychiatric symptoms, 
although patients with psychotic disorders tend to have lower rates of treatment attrition 
relative to other diagnostic groups (Nose et al. 2003; O’Brien et al. 2009). 
Treatment Perspective 
There is evidence that patients’ view of treatment influences their adherence to outpatient 
care. Attrition has been linked to dissatisfaction with treatment (Prince 2005), a desire to 
handle problems without outside assistance (Kessler et al. 2001; Priebe et al. 2005), and the 
perception that treatment is unnecessary (Kreyenbuhl et al. 2009; Rossi et al. 2008; Young et 
al. 2000). Patients also report a variety of barriers to care that interfere with their ability to 
actively participate in treatment, including the cost of care, time limitations, and concerns about 
stigma (Rossi et al. 2008; Vogt 2011; Young et al. 2000). Treatment attrition has likewise been 
linked to a poor working relationships with treatment professionals (O’Brien et al. 2009). 
Social Support 
Interpersonal relationships have been identified as playing important roles in supporting 
treatment engagement. Nonattendance at an intake session for outpatient care has been 
linked to limited family support (Kruse et al. 2002; Fischer et al. 2008a, b). Conversely, a 
recent study found that the majority of psychiatric patients engaged in outpatient care 
experienced pressure to adhere to treatment from at least one person in the previous 
6 months, with treatment professionals and family members representing the most common 
sources of treatment support (Redlich and Monahan 2006). 
Previous Treatment Engagement 
For some psychiatric patients, treatment engagement stops at the point of discharge from the 
inpatient psychiatric ward, with little or no participation in aftercare (Lingham and Scott 2002; 
Olfson et al. 2000). This initial post-discharge period appears to be the most likely time for 
patients to leave care (O’Brien et al. 2009), whereas initial participation in outpatient care is 
associated with treatment retention and more long-term treatment participation (Kreyenbuhl et 
al. 2009; Kruse et al. 2002). 
The Present Study 
The present study was designed to identify factors related to post-inpatient mental health 
treatment attrition in high-utilizing VA psychiatric patients. The study tracked patients over a 
period of 2 years following discharge from inpatient psychiatric care and utilized a well-
validated measure of treatment participation. A broad range of variables thought to be related 
to engagement were measured and investigated to better understand patient attrition from 
care. 
The present study had the following goals: 
1. Evaluate the rate of post-inpatient treatment attrition of high-utilizing psychiatric patients over 
time.  
2. Identify cognitive, social, and treatment variables associated with attrition from post-inpatient 
psychiatric care in high utilizing psychiatric patients.  
3. Identify cognitive, social, and treatment variables associated with a more rapid departure from 
post-inpatient treatment in high utilizing psychiatric patients. 
  
Method 
Treatment Perceptions Questionnaire 
Due to a lack of existing metrics to study treatment-related cognitions of psychiatric patients, 
the Treatment Perception Questionnaire (TPQ) was developed and utilized . First, focus 
groups were conducted with patients and providers within the inpatient psychiatric ward of a 
large VA hospital in the Midwest. Participants engaged in group-based conversations related 
to their expectations of the consequences of treatment participation and of persons who might 
play important roles in supporting or undermining treatment. Second, focus group information 
was used to create TPQ items that measured patients’ expectations of factors associated with 
post-discharge care. The TPQ has two major scales, related to perceived consequences of 
treatment and perceived support for treatment. Each scale comprised subscales. 
Perceived Consequences Subscales 
Patients provided two responses to a list of 31 items that described potential consequences 
(i.e., their expectations of the ways that treatment participation would change their lives) of 
continuing treatment. First they rated the likelihood of each potential consequence, then they 
rated the potential tolerability of that consequence. Subscales were created to reflect the 
perceived consequences. The subscales were labeled Interpersonal Stigma, Intrapersonal 
Stigma, Material Cost of treatment, Changes in Relationships with others, and Changes in 
Symptom levels. Subscale scores ranged from −21.0 to 21.0, with lower scores representing 
increased levels of expected negative consequences as a result of treatment participation. 
Perceived consequences scales had fair to good internal consistency, with scale alphas 
between 0.60 and 0.80. 
Perceived Social Support for Treatment Subscales 
Twelve TPQ items assessed the level of support for treatment that patients expected to 
receive from other people in their lives. Utilizing these items, subscales were created to 
represent the level of treatment support that patients expected from their Family Members and 
Treatment Providers. These TPQ subscales had subscale ranges from −21.0 to 21.0, with 
higher scores representing increased perceived treatment support from that social support. 
Perceived Social Support subscales demonstrated fair to good internal consistency, with the 
Family Member subscale having a scale alpha of 0.65 and the Treatment Providers subscale 
having a scale alpha of 0.87. 
Treatment Participation 
Short-Term Treatment Engagement 
Three treatment activities of interest were selected for investigation based on conversations 
with patients and treatment staff: attendance at psychiatrist appointments, attendance at group 
therapy sessions, and medication utilization. Three variables were created to assess patients’ 
treatment participation in these activities during the 2 months after discharge from inpatient 
psychiatric care. Utilizing an approach adopted in previous studies (e.g., Lingham and Scott 
2002), medication utilization was assessed by comparing the number of total prescriptions to 
the number renewed in time to avoid a lapse in administration. Attendance at group therapy 
sessions and psychiatrist appointments were calculated as the ratio of attended appointments 
to overall scheduled appointments. 
Long-Term Treatment Participation 
Each veteran was tracked for 2 years post-discharge. Whether they attended their scheduled 
appointments during each week of the follow-up period was recorded based on a review of 
their electronic medical records (EMRs). Using a standard suggested by the Health Plan 
Employer Data and Information Set (HEDIS, Corrigan and Nielsen 1993), 30 days (5 weeks) 
was selected as the maximum acceptable time between treatment contacts for a patient to be 
considered continuously engaged in care. HEDIS guidelines have been previously utilized in 
studies of post-discharge follow-up of psychiatric inpatients (Druss et al. 2004) and in 
evaluations of VA mental health care quality (Harris et al. 2009). Based on these guidelines, 
each veteran was rated as either remaining in treatment or leaving care during the 2 year 
follow-up period. For veterans who left treatment, the amount of time between inpatient 
discharge and loss of treatment contact was calculated. 
Demographic and Clinical Variables 
Participants’ age, race, gender, relationship status, and diagnosis were collected from EMRs. 
Each patient was categorized as having a diagnosis of a mood, psychotic, substance 
dependence, anxiety, or axis II disorder at the time of study entry. Additional treatment 
information collected from EMRs included: the number of inpatient psychiatric treatment days 
during the past year, number of lifetime psychiatric hospitalizations, and Global Assessment of 
Functioning (American Psychiatric Association 2000) score at intake into inpatient psychiatric 
care. 
Patient Screening and Research Cohort Creation 
To be included in this study, each patient had to meet the criteria established by Langdon et al. 
(2001) to be classified as a high-utilizer of services: (1) three or more lifetime psychiatric 
hospitalizations, (2) at least one psychiatric hospitalization in the year prior to the study, and 
(3) receiving inpatient psychiatric care at admission into the study. Each patient further was 
required to have prescribed psychiatric medications and planned post-discharge attendance at 
group therapy and psychiatric appointments as part of their post-inpatient psychiatric care. 
A total of 314 veterans initially completed the questionnaire. Of those who completed the 
questionnaire, 65 were excluded either due to incomplete questionnaire completion, because 
they did not meet high-utilizer status, or because they did not have assigned participation in 
one of the treatment activities of interest within their discharge treatment plans. Another 16 
patients were excluded because they belonged to groups with poor representation (e.g., 4 of 
Native American descent, 6 of Hispanic descent) and bivariate analyses suggested that they 
represented unique cohorts based on the relationship between predictor and outcome 
measures. This resulted in a final sample of 233 patients. This study was approved by the 
Institutional Review Board of the Veterans Affairs Healthcare Center at which the study was 
conducted. 
Procedure 
Patients receiving care within an inpatient psychiatric ward at a VA hospital in the Midwest 
were recruited between March and June of 2006 from within a combined inpatient treatment 
milieu setting wherein diagnostically diverse patients were treated in combined treatment 
groups and completed the TPQ in a group format. Participating patients completed an 
informed consent process and were offered $10 in VA vouchers for their participation. 
Results 
Patient Characteristics 
Patient demographic characteristics are presented in Table 1. Most patients were male and not 
in a committed relationship, and they were almost equally divided in terms of race. The sample 
was diagnostically diverse, and most had either or both a substance use and mood disorder. 
Patient clinical characteristics are also shown in Table 1, including GAF score when they 
entered the study, days of inpatient treatment over the year prior to the study, and lifetime total 
number of hospitalizations. 
Table 1 Participant demographic, illness and treatment history variables (N = 233) 
  M (SD) 
Age 49.89 (8.28) 
GAF score at intake into study 41.17 (9.61) 
Inpatient days in year prior to entry into study 8.76 (9.67) 
Total hospitalizations—lifetime 10.51 (12.03) 
  M (SD) 
Illness length (in years) 14.43 (10.34) 
  N (%) 
Gender (male) 218 (93.6) 
Race (African-American) 111 (47.6) 
Relationship status (single) 184 (79.0) 
Diagnosisa    
 Substance use disorder 181 (77.7) 
 Psychotic disorder 34 (14.6) 
 Mood disorder 148 (63.5) 
 Anxiety disorder 56 (24.0) 
 Personality disorder 37 (15.9) 
a Diagnoses were given by VA mental health professionals. Diagnostic categories are not mutually 
exclusive. Substance Use Disorder includes alcohol, cocaine, and opioid dependence diagnoses. 
Psychotic Disorder includes diagnoses of schizophrenia, psychosis NOS, and bipolar disorder with 
psychotic features. Mood Disorder includes diagnoses of depression NOS, major depression, and 
bipolar disorder without psychotic features. Anxiety Disorder includes post-traumatic stress disorder, 
obsessive-compulsive disorder, and anxiety disorder NOS. Personality Disorder means diagnoses of 
personality disorders 
Prediction of Attrition from Care 
During the course of the 2-year follow-up period, 202 of 232 patients (88.0 %) dropped out of 
care based on a period of 5 weeks or greater without contact with their treatment staff. To 
evaluate attrition status, a logistic regression equation was calculated, with the dichotomous 
outcome variable of treatment engagement status at the end of the 2-year follow-up period 
(Table 2). Patient demographic characteristics, diagnosis, treatment history, and treatment 
expectation, as well as short-term treatment engagement measures, were used as predictor 
variables. This resulted in a significant regression model (χ2(21) = 55.11, p < .001, R 2 = 0.87). 
Attrition was significantly associated with younger age, male gender, increased expectations of 
intrapersonal stigma as a result of treatment, less short-term attendance at group therapy 
sessions, and fewer medications picked up from the pharmacy in the 3 months following 
discharge from inpatient care. 
Table 2 Summary of logistic regression analyses predicting treatment attrition status (N = 233) 
Predictor variable B  SE B  OR 95 % CI for OR 
Demographic measures 
 Age 0.09* 0.04 1.10 1.01–1.19 
 Gender (1 = male) 2.43** 0.96 10.41 1.57–68.90 
 Race (1 = African-American) 0.27 0.53 1.31 0.47–3.68 
Treatment measures 
 GAF score at admission −0.04 0.03 0.96 0.91–1.01 
Predictor variable B  SE B  OR 95 % CI for OR 
 Inpatient days in year prior 0.02 0.02 1.02 0.98–1.07 
 Number of lifetime inpatient admissions 0.03 0.02 1.03 0.99–1.07 
Diagnostic status (1 = positive) 
 Substance use disorder 0.56 0.61 1.74 0.53–5.74 
 Psychotic disorder 0.11 0.80 1.12 0.23–5.34 
 Mood disorder 0.81 0.62 2.24 0.67–7.51 
 Anxiety disorder −0.44 0.60 0.64 0.20–2.08 
 Personality disorder −0.93 0.61 0.39 0.12–1.29 
Treatment expectations 
 Expected social stigma from treatment 0.06 0.05 1.06 0.97–1.17 
 Expected internal stigma from treatment −0.14 0.07 0.87* 0.76–0.99 
 Expected material cost of treatment −0.08 0.08 0.92 0.79–1.08 
 Expected social consequences of treatment −0.01 0.07 1.00 0.88–1.14 
 Expected symptom change from treatment 0.06 0.06 1.06 0.94–1.19 
 Perceived treatment support from family −0.04 0.04 0.96 0.88–1.04 
 Perceived treatment support from treatment staff 0.03 0.05 1.03 0.94–1.13 
Short-term treatment engagement measures 
 Psychiatrist appointment attendance 0.22 0.61 1.25 0.38–4.13 
 Group therapy attendance 2.50 0.93 12.18** 1.97–75.34 
 Medication pick-up 1.60 0.75 4.71* 1.08–20.54 
Model: 𝜒𝜒2(21) =  55.11, 𝑝𝑝 <  . 001, Adjusted 𝑅𝑅 2 =  . 87 
* 𝑝𝑝 <  . 05; ** 𝑝𝑝 <  . 01; *** 𝑝𝑝 <  . 001 
 
A second regression equation was calculated to predict time until treatment attrition, using only 
those veterans who left treatment during the follow-up period (𝑛𝑛 =  202). Once again, patient 
demographic, diagnostic, treatment history, treatment expectation, and short-term treatment 
engagement measures were used as predictor variables. The results are summarized in 
Table 3. The resultant model was significant (𝑅𝑅 =  0.54, 𝐹𝐹(21, 180) =  3.50, 𝑝𝑝 <  . 001, 
𝑅𝑅 2 =  0.29). Earlier attrition was significantly associated with fewer inpatient psychiatric days 
in the year prior to the study, fewer lifetime psychiatric hospitalizations, increased expectations 
of material cost resulting from treatment participation, increased perceived treatment support 
from family members, less short-term post-discharge attendance at psychiatrist appointments, 
and less short-term post-discharge attendance at group therapy sessions. 
Table 3 Summary of regression analyses predicting time to treatment attrition (N = 202) 
Predictor variable B  SE B  t  
Demographic measures 
 Age 0.22 0.19 1.18 
Predictor variable B  SE B  t  
 Gender (1 = male) 5.36 5.87 0.91 
 Race (1 = African-American) 2.35 2.92 0.81 
Treatment measures 
 GAF score at admission 0.26 0.15 1.70 
 Inpatient days in year prior 0.73 0.18 4.03** 
 Number of lifetime inpatient admissions 0.33 0.14 2.40* 
Diagnostic status (1 = positive) 
 Substance use disorder 6.22 3.71 1.68 
 Psychotic disorder −2.32 4.44 −0.52 
 Mood disorder 2.91 3.17 0.92 
 Anxiety disorder 5.14 3.55 1.45 
 Personality disorder 3.48 4.01 0.87 
Treatment expectations 
 Expected social stigma from treatment −0.06 0.25 −0.26 
 Expected internal stigma from treatment −0.15 0.40 −0.39 
 Expected material cost of treatment 0.89 0.41 2.18* 
 Expected social consequences of treatment −0.22 0.41 −0.55 
 Expected symptom change from treatment 0.22 0.32 0.71 
 Perceived treatment support from family −0.51 0.25 −1.99* 
 Perceived treatment support from treatment staff 0.15 0.24 0.62 
Short-term treatment engagement measures 
 Psychiatrist appointment attendance 8.76 3.36 2.61** 
 Group therapy attendance 8.36 3.70 2.26* 
 Medication pick-up 3.19 3.91 0.82 
Model: 𝐹𝐹(21, 180) =  3.50, 𝑝𝑝 <  . 001, Adjusted 𝑅𝑅 2 =  . 29 
* 𝑝𝑝 <  . 05; ** 𝑝𝑝 <  . 01; *** 𝑝𝑝 <  . 001 
S 
urvival Analyses of Treatment Attrition Status 
 
Survival analyses were conducted to predict treatment attrition for the entire sample of 233 
patients, and the associated survival plot is displayed in Fig. 1. The results illustrated a high 
initial loss of veterans followed by a steady loss of additional veterans throughout the follow-up 
period. Several points of interest were identified to better describe this graph in Table 4. Note 
that discrepancies between numbers and percentages reflect adjustments for loss of veterans 
who did not complete the full follow-up period (due to death or delayed release from intensive 
care). 
 
Fig. 1 Treatment contact split by short-team group attendance (N = 233) 
Table 4 Treatment contact survival analysis results: total sample and sample split by short-term post-
discharge attendance at group therapy sessions (N = 233) 
Survival % Total sample Low short-term group 
treatment attendance 
High short-term group 
treatment attendance 
(N = 233) (N = 133) (N = 100) 
N  Week Slopea  N  Week Slope N  Week Slope 
100 233 0 n/ab  133 0 n/a 100 0 n/a 
75 176 3 −19.40 95 3 −8.31 73 9 −5.00 
50 115 14 −5.29 65 11 −3.62 49 28 −1.79 
25 57 44 −1.93 32 33 −1.52 24 77 −0.67 
Final 20 104 −0.51 6 104 −0.33 15 104 −0.17 
  Final % Overall slope Final % Overall slope Final % Overall slope 
Overall 12.00 −1.98 7.00 −1.18 18.50 −0.78 
Variable Low attendance High attendance df  χ2        
(N = 133) (N = 100)       
In treatment after 2 years 7.50 % 18.50 % 1 −2.14*       
Variable M  SD M  SD df  χ2        
Time to treatment attrition 15.63 19.25 22.26 23.35 156.76 7.46**       
* 𝑝𝑝 <  . 05; ** 𝑝𝑝 <  . 01 
a Slope measured in average number of patients lost to treatment contact for 5 weeks or longer per 
week for the period between that and the previous point in the survival plot 
b Slopes are not listed for 100 % survival points as these represent the beginning points of the survival 
plots, with no previous points on the line with which to generate a slope 
Post-Hoc Analyses Using Short-Term Group Attendance 
Upon reviewing the results of the regression analyses, it appeared that post-discharge short-
term group therapy attendance was an important factor in both treatment attrition and time to 
attrition. Post-hoc analyses were conducted to examine this variable further. First, two groups 
were created based on a median split on group therapy attendance (𝑀𝑀 =  0.71). One group 
(Low Attendance) comprised patients with 71 % or less rate of group attendance (𝑁𝑁 =  133) 
and the other group (High Attendance) comprised those with 72 % or more rate of attendance 
(𝑁𝑁 =  100). Next, new survival plots were generated for each of these two groups, and these 
results are also presented in Fig. 1. Results indicated that 18.5 % of the High Attendance 
group members survived until the end of the follow-up period, compared to 7.00 % of the Low 
Attendance group members (𝜒𝜒2 [df =  1] =  2.14, 𝑝𝑝 <  . 05). For the High Attendance group 
members, the average time to attrition (in days) was 22.26 (𝑆𝑆𝑆𝑆 =  23.35) versus 15.63 (𝑆𝑆𝑆𝑆 =  19.25) for the Low Attendance group (t =  7.46, p <  . 001). 
Discussion 
The problem of psychiatric patients utilizing unusually high levels of resources, especially 
expensive inpatient care, is paradoxically related to limited participation in outpatient care (e.g., 
Prince 2005). In this study, we attempted to evaluate further person-specific factors related to 
poor compliance with outpatient follow-up care by patients recently discharged from inpatient 
units. 
Across the entire sample, 88.0 % left treatment during the 2-year follow-up period, with 
67.80 % attrition by 6 months, 81.60 % attrition at 1 year, and 87.40 % attrition by 18 months. 
These numbers are noticeably higher than the 30 % rate reported by O’Brien et al. (2009) or 
the 58 % rate cited by Kreyenbuhl et al. (2009). These discrepancies in attrition rates suggest 
that further research into the rates of longitudinal attrition in psychiatric patients is merited and 
point to the need for standardized definitions and measures of attrition. The use of a 
standardized measure of treatment adequacy within this study (the HEDIS measure of 
5 weeks between treatment contacts) represents a positive step toward the establishment of 
such definitions and measurement metrics. 
These results suggest that younger male patients were most likely to leave treatment, 
especially if they expected to experience more internal stigma as a result of treatment. These 
results also illuminated some early indicators of potential attrition. Patients who were less 
compliant with medication prescriptions (i.e., who picked up their prescriptions from the 
pharmacy less frequently) and who had poorer short-term attendance at post-discharge group 
therapy sessions were most likely to disengage from ongoing outpatient treatment and to 
disengage more quickly. 
These findings are similar to previous work in this area. Younger age and male gender have 
been found to be associated with a loss of treatment contact within VA psychiatric patients 
(McCarthy et al. 2007; O’Brien et al. 2009). Likewise, concerns related to negative self-image 
have been established as barriers to care engagement (e.g., Perese 2007). As far as we know, 
this is the first study to show a relationship between treatment attrition and poor participation in 
specific treatment behaviors (i.e., group and medications) in the immediate period following 
discharge from inpatient care. 
Among patients who left treatment, earlier departure was associated with fewer prior-year 
inpatient psychiatric days, fewer lifetime psychiatric hospitalizations, increased expectations of 
material cost of treatment, higher levels of perceived family treatment support, and less short-
term post-discharge attendance at psychiatric and group therapy session appointments The 
association between past and present service utilization may reflect a lack of perceived need 
for treatment by the patients in the study, a factor important in supporting treatment 
engagement (Elbogen et al. 2006). While the relationship between short-term and long-term 
engagement may be due in part to an overlap in the measurement of these variables, it is 
interesting to note that the treatment behaviors associated with care retention all had a social 
interaction component, while the behavior unrelated to time to attrition (medication pickup) is 
performed in isolation. 
The importance of short-term group therapy attendance is worth further exploration. Almost the 
entire group (97.2 %) of the low attendance group members left during the 2-year follow-up 
period, while only 75 % of the high attendance group left care. There were also differences in 
attrition rates between the two groups, with the low attendance group reaching the 25 % 
attrition mark seven times more quickly and both the 50 and 75 % attrition mark more than five 
times as quickly as the high attendance group. These groups had different patterns of attrition, 
with the high attendance group leaving in a steady manner throughout the follow-up period 
while the low attendance group experienced initial extreme attrition followed by steady, 
moderate-level loss. 
Our study found that increased perceived family treatment support was associated with shorter 
time to attrition, a result that runs contrary to previous research on treatment engagement in 
psychiatric patients (e.g., Fischer et al. 2008a, b) and suggests the need for collaboration 
between families and caregivers of patients. The relationship between increased perceived 
cost of care and earlier attrition mirrors previous work that found increased attrition in patients 
who expected care to be more expensive or require increased time commitments (Rossi et al. 
2002; Young et al. 2000). This suggests that patients transitioning from inpatient to outpatient 
care would benefit from problem-solving and case management services to assist them in 
managing resources necessary for effective participation in outpatient mental health care. 
Also of note was the lack of significant relationships between variables that might be expected 
to predict attrition. Diagnosis was generally unrelated to treatment engagement, despite 
previous work that found that the presence of psychotic (Rossi et al. 2002), substance 
dependent (Ball et al. 2006; Fischer et al. 2001), and mood symptoms (Webb et al. 2007) are 
associated with differential rates of treatment engagement. 
Evidence for Subpopulations of Patients 
Overall, the results of the survival analyses suggest that there are multiple sub-populations of 
psychiatric patients, rather than the two (“engaged” versus “disengaged”) considered in this 
study. The rates of attrition in the study suggest at least three groups of patients: those who 
leave treatment shortly after discharge from inpatient care, those who remain engaged 
throughout, and those who have initial care participation followed by later disengagement. 
Evidence for a completely nonparticipatory sub-group can be seen in the drastic loss of 
patients following discharge from intensive psychiatric hospitalization, with more than 25 % 
leaving within the first 3 weeks of care. A group committed to long-term engagement is 
suggested by the cohort remaining throughout the follow-up period (12 % of the overall 
sample). The remaining 63 % of the graph does not clearly fit into either other group and is 
characterized by a gradually-decreasing slope with initially high levels of attrition that become 
more moderate over time. Differences in engagement of these three groups suggests 
differences in treatment perspective, with those immediately disengaging perhaps viewing 
treatment as unnecessary, those who are relatively committed perhaps seeing treatment as 
essential, and the rest viewing treatment as initially important but less so as symptoms 
stabilize. It is likely that increased patient functioning is associated with less perceived need for 
ongoing assistance in managing symptoms, a finding that is supported by previous research 
on reasons for treatment disengagement (Kreyenbuhl et al. 2009). The additional finding that 
the number of past-year psychiatric hospitalizations and lifetime hospitalizations were 
associated with treatment retention suggests that symptom chronicity and symptom severity 
may both shape the level of perceived need for treatment participation. 
Supporting these ideas, the middle graph resembles the dose-response model (Howard et al. 
1986), which suggests that patients terminate outpatient psychotherapy after an improvement 
in symptom levels. Within the dose-response curve, the rates of patients who had not yet 
experienced symptom improvement were: 64 % after 3 sessions, 52 % after 7 sessions, 32 % 
after 16 sessions, 26 % after 52 sessions, and 15 % after 104 sessions (Howard et al. 1986). 
Within the present study, 71 % of veterans remained in treatment after 3 weeks, 56 % 
remained after 7 weeks, 46 % remained after 16 weeks, 22 % remained after 52 weeks, and 
12 % remained after 104 weeks. The similarity between these graphs suggests that persons 
within this third group may have experienced symptom reduction then chose to leave treatment 
as they felt that ongoing treatment participation was unnecessary for effective management of 
their symptoms, a pattern consistent with many other psychological conditions as well as 
previous research on psychiatric patients (O’Brien et al. 2009). Unfortunately, given the high 
level of both recent and past emergency psychiatric care utilization of this population, these 
results suggest that such patients may be overestimating their ability to independently manage 
their symptoms or may not realize the need for help until their symptoms are at emergent 
levels. Counter intuitively, providers might find better outcomes for high-utilizing patients by 
actively reaching out to patients who appear to require the least support following inpatient 
care. 
A notable result of this study is the high rate of treatment attrition within high-utilizing 
psychiatric patients. Elevated rates of attrition occurred even within the group with the highest 
rate of treatment success, suggesting that such outcomes are characteristic of this population 
and likely to occur even when patients are provided with the most appropriate and well-
implemented treatment. The transition from inpatient to outpatient care appears to be a crucial 
period during which patients are very likely to leave. However, the increased retention 
associated with group therapy participation speaks to the importance of patient-to-patient 
relationships for psychiatric patients. These patients would likely benefit from staff efforts 
aimed at fostering such relationships, both during and immediately after inpatient psychiatric 
care. 
Study Limitations 
Several limitations affected study results. While the pool was well-distributed among some 
variables such as relationship status, age, and race, several other variables such as gender 
were highly constricted within the sample. Also of concern is the broad definition of treatment 
as “any contact between providers and patients.” This measure likely inflated the estimate of 
treatment involvement, as persons were considered to be engaged even if they were only 
attending to portions of their prescribed care. 
Conclusions and Future Directions 
This study suggests that there are multiple sub-sets of high-utilizing psychiatric patients with 
regard to treatment engagement. It is likely that the process of treatment engagement is fluid, 
with patients entering and leaving treatment repeatedly over time rather than simply remaining 
in care throughout. While traditional survival analysis techniques allowed a partial investigation 
into the relationships between these variables, future work using repeated event survival 
analysis could provide insights into the way these variables play out in care. 
These results also indicate that social and cognitive factors play important roles in preventing 
attrition from care for this group. The role of other important factors such as emotion or 
motivation have not been adequately investigated and hold the potential to allow a more 
complete understanding of the reasons for patient disengagement from outpatient mental 
health care. 
This study represents a systematic evaluation of factors predictive of attrition from outpatient 
care by high-utilizing psychiatric patients through the use of a well-supported measure of 
treatment contact adequacy. It also represents a first step toward the development of 
interventions aimed at reducing emergency psychiatric services use by high-utilizing patients 
by highlighting clinical and treatment-related factors associated with attrition, assisting 
clinicians in identifying patients most likely to leave care and treatment factors (group therapy) 
associated with greater treatment retention for this group. 
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